Nine Monthly Results Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
684.44
602.27
456.00
381.43
330.50
396.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
684.44
602.27
456.00
381.43
330.50
396.51
Raw Material Cost
448.51
371.89
301.88
241.81
189.51
177.41
Purchase of Finished goods
1.37
0.00
0.00
0.00
0.00
0.08
(Increase) / Decrease In Stocks
-43.68
-15.55
-36.16
-30.23
-39.30
0.38
Employee Cost
64.12
52.92
48.99
49.29
57.30
65.30
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
124.93
112.16
97.36
95.61
90.69
166.27
Total Expenditure (Excl Depreciation)
595.25
521.42
412.07
356.48
298.20
409.43
Operating Profit (PBDIT) excl Other Income
89.19
80.85
43.93
24.95
32.30
-12.92
Other Income
23.58
17.86
17.70
7.26
3.94
18.79
Operating Profit (PBDIT)
112.77
98.71
61.63
32.21
36.24
5.87
Interest
10.63
12.89
24.74
27.55
39.45
3.38
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
102.14
85.82
36.89
4.66
-3.21
2.49
Depreciation
25.68
24.82
47.57
60.40
88.59
94.72
Profit Before Tax
76.47
60.99
-10.68
-55.76
-91.80
-92.21
Tax
-0.15
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
76.62
60.99
-10.68
-55.76
-91.80
-92.21
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
60.39
0.00
0.00
Net Profit
76.62
60.99
-10.68
4.64
-91.80
-92.21
Share in Profit of Associates
0.74
-2.35
-2.14
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
77.37
58.64
-12.82
4.64
-91.80
-92.21
Equity Capital
50.72
50.72
40.82
40.82
40.82
88.96
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
4.1
6.18
1.86
-3.4
-10.96
-3.11
Operating Profit Margin (Excl OI)
13.03%
13.42%
9.63%
6.54%
9.77%
-3.26%
Gross Profit Margin
14.92%
14.25%
8.09%
1.22%
-0.97%
0.63%
PAT Margin
11.19%
10.13%
-2.34%
-14.62%
-27.78%
-23.26%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 13.64% vs 32.08% in Dec 2023
Consolidate Net Profit
YoY Growth in nine months ended Dec 2024 is 31.94% vs 557.41% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 10.32% vs 84.04% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is -17.53% vs -47.90% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023
Compare Nine Monthly Results Of Orchid Pharma With
Figures in Rs cr
Consolidate Nine Monthly Results
Change(INR)
Change(%)
Net Sales
684.44
9,199.93
-8,515.49
-92.56%
Other Operating Income
0.00
0.00
0.00
Total Operating income
684.44
9,199.93
-8,515.49
-92.56%
Raw Material Cost
448.51
1,471.08
-1,022.57
-69.51%
Purchase of Finished goods
1.37
1,244.57
-1,243.20
-99.89%
(Increase) / Decrease In Stocks
-43.68
-93.01
49.33
53.04%
Employee Cost
64.12
1,989.92
-1,925.80
-96.78%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
124.93
2,225.77
-2,100.84
-94.39%
Total Expenditure (Excl Depreciation)
595.25
6,838.33
-6,243.08
-91.30%
Operating Profit (PBDIT) excl Other Income
89.19
2,361.60
-2,272.41
-96.22%
Other Income
23.58
287.35
-263.77
-91.79%
Operating Profit (PBDIT)
112.77
2,648.95
-2,536.18
-95.74%
Interest
10.63
238.94
-228.31
-95.55%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
102.14
2,410.01
-2,307.87
-95.76%
Depreciation
25.68
405.66
-379.98
-93.67%
Profit Before Tax
76.47
2,007.79
-1,931.32
-96.19%
Tax
-0.15
427.80
-427.95
-100.04%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
76.62
1,576.55
-1,499.93
-95.14%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
76.62
1,576.55
-1,499.93
-95.14%
Share in Profit of Associates
0.74
9.92
-9.18
-92.54%
Minority Interest
0.00
-7.70
7.70
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
77.37
1,570.19
-1,492.82
-95.07%
Equity Capital
50.72
40.06
10.66
26.61%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
14.92%
26.20%
0.00
-11.28%
PAT Margin
11.19%
17.14%
0.00
-5.95%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 684.44 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 13.64% vs 32.08% in Dec 2023
Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 77.37 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 31.94% vs 557.41% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 89.19 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 10.32% vs 84.04% in Dec 2023
Nine Monthly - Interest
Interest 10.63 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is -17.53% vs -47.90% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.03%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
